Luminex Corporation (LMNX) to Issue Quarterly Dividend of $0.06 on July 14th

Luminex Corporation (NASDAQ:LMNX) declared a quarterly dividend on Thursday, May 25th, Wall Street Journal reports. Shareholders of record on Friday, June 23rd will be given a dividend of 0.06 per share by the medical instruments supplier on Friday, July 14th. This represents a $0.24 annualized dividend and a yield of 1.17%. The ex-dividend date is Wednesday, June 21st.

Luminex Corporation (LMNX) opened at 20.58 on Tuesday. The firm has a 50-day moving average price of $20.65 and a 200 day moving average price of $19.53. The stock has a market cap of $904.00 million, a PE ratio of 63.91 and a beta of 0.35. Luminex Corporation has a 52-week low of $17.64 and a 52-week high of $23.75.

Luminex Corporation (NASDAQ:LMNX) last issued its quarterly earnings data on Monday, May 1st. The medical instruments supplier reported $0.28 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.16 by $0.12. Luminex Corporation had a return on equity of 5.48% and a net margin of 5.00%. The company had revenue of $77.80 million during the quarter, compared to analyst estimates of $74.25 million. During the same quarter in the previous year, the company posted $0.29 earnings per share. Luminex Corporation’s revenue was up 23.5% compared to the same quarter last year. On average, analysts forecast that Luminex Corporation will post $0.52 earnings per share for the current fiscal year.

WARNING: This story was first published by Ticker Report and is the sole property of of Ticker Report. If you are viewing this story on another website, it was copied illegally and reposted in violation of US & international trademark and copyright legislation. The original version of this story can be accessed at https://www.tickerreport.com/banking-finance/2654366/luminex-corporation-lmnx-to-issue-quarterly-dividend-of-0-06-on-july-14th.html.

In related news, Director G Walter Loewenbaum II sold 25,000 shares of Luminex Corporation stock in a transaction on Tuesday, May 23rd. The stock was sold at an average price of $20.23, for a total transaction of $505,750.00. Following the transaction, the director now directly owns 738,896 shares in the company, valued at $14,947,866.08. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Insiders sold 75,000 shares of company stock valued at $1,527,500 in the last ninety days. 6.90% of the stock is currently owned by corporate insiders.

A hedge fund recently raised its stake in Luminex Corporation stock. Teachers Advisors LLC increased its stake in shares of Luminex Corporation (NASDAQ:LMNX) by 4.7% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 87,489 shares of the medical instruments supplier’s stock after buying an additional 3,950 shares during the period. Teachers Advisors LLC owned about 0.21% of Luminex Corporation worth $1,607,000 at the end of the most recent reporting period. 78.37% of the stock is owned by institutional investors.

Several analysts recently commented on the company. ValuEngine raised Luminex Corporation from a “sell” rating to a “hold” rating in a report on Thursday, May 11th. Jefferies Group LLC reaffirmed a “hold” rating and issued a $21.00 price objective on shares of Luminex Corporation in a report on Friday, June 9th. Zacks Investment Research raised Luminex Corporation from a “hold” rating to a “strong-buy” rating and set a $24.00 price objective for the company in a report on Thursday, May 4th. Finally, TheStreet raised Luminex Corporation from a “c+” rating to a “b-” rating in a report on Friday, May 19th. One analyst has rated the stock with a sell rating, five have given a hold rating, one has assigned a buy rating and one has given a strong buy rating to the stock. The stock has a consensus rating of “Hold” and an average price target of $21.83.

About Luminex Corporation

Luminex Corporation develops, manufactures and sells biological testing technologies with applications throughout the diagnostics, pharmaceutical and life sciences industries. The Company’s products are focused on the molecular diagnostic testing market, which includes human genetics, personalized medicine and infectious disease segments.new TradingView.widget({ “height”: 400, “width”: 625, “symbol”: “NASDAQ:LMNX”, “interval”: “D”, “timezone”: “Etc/UTC”, “theme”: “White”, “style”: “1”, “locale”: “en”, “toolbar_bg”: “#f1f3f6”, “enable_publishing”: false, “hideideas”: true, “referral_id”: “2588”});

Receive News & Ratings for Luminex Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Luminex Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
President Trump Hurting Tourism in the U.S.
President Trump Hurting Tourism in the U.S.
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Blue Apron Filed Thursday for Public Offering
Blue Apron Filed Thursday for Public Offering
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Large Auto Lender Checked Just 8% of Incomes for Applicants
Large Auto Lender Checked Just 8% of Incomes for Applicants


Leave a Reply

© 2006-2017 Ticker Report. Google+.